News
Latest News and Press Releases
Axcelead Drug Discovery Partners was rated as “Excellent” by Japan Agency for Medical Research and Development (AMED)* in a program for “Drug Discovery Seeds Development”
Axcelead Drug Discovery Partners, Inc. (Axcelead DDP) has supported 24 research projects aiming at new drug development...
xFOREST Therapeutics, Axcelead DDP and Kyowa Kirin Initiated an Collaboration in RNA Structures Targeted Drug Discovering
Tokyo, Japan, October ##, 2021 — xFOREST Therapeutics Co., Ltd. (Headquarter: Kamigyo-ku, Kyoto, Japan, President and CEO:...
Axcelead DDP participates in “MONSTAR-SCREEN-2” of the 4th-stage industry-academia collaborative Cancer Genome Screening Project for Individualized Medicine in Japan “SCRUM-Japan”, as a joint research institute
We are pleased to announce that Axcelead Drug Discovery Partners Inc., (Headquarters: Fujisawa, Kanagawa, JAPAN, CEO: Yoshinori...
Axcelead has entered into a comprehensive agreement including transfer of key drug discovery platforms with a major Japanese pharmaceutical company
Axcelead Drug Discovery Partners Co., Ltd. (Headquarters: Fujisawa, Kanagawa, President, CEO: Yoshinori Ikeura; Axcelead) announces that the company...
Axcelead’s response to the COVID-19 emergency declaration in January 2021
On January 7, the Japanese government declared State of Emergency to prevent the spread of COVID-19 pandemic...